Regulus Therapeutics Inc.
) was a big mover last session with its shares rising nearly 6% on
the day. The move came on solid volume too with far more shares
changing hands than in a normal session. This breaks the recent
trend of the company, as the stock is now trading above the past
one month's volatile price range of $6.56 to $7.76.
This biopharmaceutical company has seen no estimate revision in the
last 30 days. The Zacks Consensus Estimate hasn't remained in trend
either. Yesterday's price action is encouraging though, so make
sure to keep a close watch on this firm in the near future.
Regulus currently has a Zacks Rank #3 (Hold) while its
Some better-ranked stocks worth considering in the Med-Drugs
Lannett Company, Inc.
Sagent Pharmaceuticals, Inc.
). While LCI sports a Zacks Rank #1 (Strong Buy), ZGNX and SGNT
carry a Zacks Rank #2 (Buy).
Want the latest recommendations from Zacks Investment Research?
Today, you can download
7 Best Stocks for the Next 30 Days
Click to get this free report >>
LANNETT INC (LCI): Free Stock Analysis Report
REGULUS THERAP (RGLS): Free Stock Analysis
SAGENT PHARMA (SGNT): Free Stock Analysis
ZOGENIX INC (ZGNX): Free Stock Analysis Report
To read this article on Zacks.com click here.